View Older Stories View More Recent Stories

Aug 25, 2020 07:33AM Knight and TherapeuticsMD (TXMD) Announce Health Canada Approval of IMVEXXY
Aug 25, 2020 07:30AM Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®
Aug 6, 2020 06:50AM TherapeuticsMD® Announces Second Quarter 2020 Financial Results
Jul 29, 2020 06:50AM TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020
Jul 15, 2020 09:10AM TherapeuticsMD (TXMD) and Nurx Expand Access to ANNOVERA
Jul 15, 2020 06:50AM TherapeuticsMD and Nurx Expand Access to ANNOVERA®
Jun 1, 2020 06:55AM TherapeuticsMD (TXMD) Announces James C. D’Arecca as New CFO, Following Retirement of CFO Daniel A. Cartwright
Jun 1, 2020 06:50AM TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer
May 8, 2020 06:50AM  TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference
Apr 29, 2020 06:50AM TherapeuticsMD (TXMD) Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA
Apr 29, 2020 06:50AM TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®
Apr 28, 2020 06:50AM TherapeuticsMD to Report First Quarter 2020 Results on May 6, 2020
Apr 22, 2020 07:07AM TherapeuticsMD (TXMD) Appoints Tommy G. Thompson to Board
Apr 22, 2020 06:50AM TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director
Mar 26, 2020 04:19PM TherapeuticsMD (TXMD) is Suspending 2020 Financial Guidance
Mar 26, 2020 04:05PM TherapeuticsMD Provides COVID-19-Related Business Update
Mar 24, 2020 07:53AM TherapeuticsMD (TXMD) Announces Paul Bisaro and Gail Naughton, Ph.D. to Board
Mar 24, 2020 07:45AM TherapeuticsMD Strengthens Board with Appointment of Industry Leaders
Mar 16, 2020 06:45AM TherapeuticsMD (TXMD) Announces Business Update on COVID-19 Pandemic
Mar 16, 2020 06:00AM TherapeuticsMD Provides Business Update on COVID-19 Pandemic
Feb 27, 2020 07:00AM TherapeuticsMD Announces Participation at the Cowen 40th Annual Healthcare Conference
Feb 13, 2020 06:30AM TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector
Feb 10, 2020 06:30AM TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020
Feb 3, 2020 06:32AM TherapeuticsMD (TXMD) Announces NDA Prior Approval Efficacy Supplement to FDA for Lower Dose of BIJUVA
Feb 3, 2020 06:30AM TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®
Jan 7, 2020 06:30AM TherapeuticsMD, an Innovative Women’s Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women’s Health Products
Jan 7, 2020 06:30AM TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products
Jan 6, 2020 06:55AM TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference
Dec 30, 2019 06:55AM TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners
Nov 26, 2019 07:30AM Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada
Nov 12, 2019 07:00AM TherapeuticsMD Announces Participation at the Stifel 2019 Healthcare Conference
Nov 6, 2019 04:05PM TherapeuticsMD Announces Third Quarter 2019 Financial Results
Nov 1, 2019 04:05PM TherapeuticsMD to Report Third Quarter 2019 Results on November 6, 2019
Oct 30, 2019 05:05PM Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada
Oct 24, 2019 09:21AM Pre-Open 10/24: (TSLA) (AYR) (PYPL) Higher (ACOR) (TWTR) (TXMD) Lower (more...)
Oct 11, 2019 07:00AM TherapeuticsMD Announces Presentations on ANNOVERA™ at the 2019 Annual Meeting of the American Society for Reproductive Medicine
Oct 10, 2019 06:45AM TherapeuticsMD Vice President of Business Development Named Finalist in 16th Annual Stevie® Awards for Women in Business
Sep 26, 2019 07:00AM TherapeuticsMD Announces Participation at the 2019 Cantor Healthcare Conference
Sep 24, 2019 07:00AM TherapeuticsMD Announces Multiple Presentations Related to IMVEXXY® and BIJUVA® at the 2019 Annual Meeting of the North American Menopause Society
Aug 6, 2019 04:05PM TherapeuticsMD Announces Second Quarter 2019 Financial Results
Jul 25, 2019 07:00AM TherapeuticsMD to Report Second Quarter 2019 Results on August 6, 2019
Jun 10, 2019 07:00AM TherapeuticsMD to Host Investor and Analyst Day Today
Jun 7, 2019 07:16AM TherapeuticsMD (TXMD) Reports Exclusive License and Supply Agreement with Theramex to Commercialize BIJUVA & IMVEXXY Outside the U.S.
Jun 7, 2019 07:15AM TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
May 29, 2019 07:00AM TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City
May 8, 2019 07:00AM TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference
May 6, 2019 04:05PM TherapeuticsMD Announces First Quarter 2019 Financial Results
May 6, 2019 07:00AM TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Women’s Menopausal Symptoms Affect Men
May 3, 2019 07:00AM TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the American College of Obstetricians and Gynecologists 2019 Annual Meeting
Apr 29, 2019 07:00AM TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019
View More Recent Stories View Older Stories